Total planned funding: $287,754,022
Allocations
Countries/Regions
Eswatini | $287,754,022 |
Organizational Types
Private Contractor | $72,503,896 |
Unknown | $55,418,306 |
NGO | $53,228,603 |
University | $49,045,746 |
Own Agency | $31,968,078 |
FBO | $10,806,488 |
Host Country Government Agency | $9,422,247 |
Multi-lateral Agency | $3,030,564 |
Other USG Agency | $2,280,094 |
Implementing Agency | $50,000 |
Program Areas
Care | $83,133,071 |
Treatment | $76,077,707 |
Prevention | $56,029,041 |
Governance and Systems | $31,243,710 |
Testing | $23,090,498 |
Management and Operations | $18,179,995 |
Budget Codes
HTXS: Treatment: Adult Treatment | $64,899,626 |
HBHC: Care: Adult Care and Support | $33,029,282 |
HKID: Care: Orphans and Vulnerable Children | $29,586,636 |
HVCT: Testing: HIV Testing and Counseling | $23,090,498 |
HVOP: Sexual Prevention: Other Sexual Prevention | $20,060,762 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,352,883 |
HVMS: Management and Operations | $18,179,995 |
HVSI: Strategic Information | $18,038,813 |
HVTB: Care: TB/HIV | $14,144,923 |
OHSS: Health Systems Strengthening | $9,134,574 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,958,502 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,216,894 |
PDTX: Treatment: Pediatric Treatment | $6,672,064 |
PDCS: Care: Pediatric Care and Support | $6,372,230 |
HTXD: Treatment: ARV Drugs | $4,506,017 |
HLAB: Laboratory Infrastructure | $4,070,323 |
HMBL: Biomedical Prevention: Blood Safety | $440,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$38,182,370
Countries/Regions
Not Available:
$37,108,440
Countries/Regions
Pact, Inc.:
$34,085,259
Countries/Regions
Chemonics International:
$16,579,695
Countries/Regions